Menopausal hormone therapy was associated with a reduced risk of low bone mineral density (BMD) among postmenopausal women in a retrospective cohort study.
Read more at: https://www.medpagetoday.com/meetingcoverage/endo/121818
Clinical guidance still calls for a nuanced approach in postmenopausal women
